Forgot Password

Stroke cord blood trials

Study of purified umbilical cord blood CD34+ stem cell on chronic ischaemic stroke

This study is being conducted by researchers at the China Medical University Hospital in Taiwan. The purpose of the study is to determine the safety and effectiveness of brain transplants of CD34+ stem cells obtained from umbilical cord blood. The aim is to recruit participants between 35 years to 70 years of age who have had an ischaemic stroke more than 6 months and less than 60 months ago. Participants will receive umbilical cord blood stem cells injected into the brain around the site damaged by stroke, in combination with antiplatelet medication and rehabilitation. The donor (allogeneic) cord blood units will be obtained from cord blood banks in USA and Taiwan and will be closely HLA ‘matched’ to the recipient. The study start date was January 2013.

Location: Taichung, Taiwan
Trial design: Safety and efficacy
Status: Not yet recruiting
Find out more